Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļAXGN
āļāļ·āđāļāļāļĢāļīāļĐāļąāļAxoGen Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 17, 1986
āļāļĩāļāļĩāđāļMr. Michael Donald (Mike) Dale
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ451
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 17
āļāļĩāđāļāļĒāļđāđ13631 Progress Blvd.
āđāļĄāļ·āļāļALACHUA
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ Capital Market Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ32615
āđāļāļĢāļĻāļąāļāļāđ13864626817
āđāļ§āđāļāđāļāļāđhttps://www.axogeninc.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļAXGN
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 17, 1986
āļāļĩāļāļĩāđāļMr. Michael Donald (Mike) Dale
Mr. Erick Wayne Devinney
Chief Innovation Officer
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Lindsey Hartley
Chief Financial Officer
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
Mr. John H. Johnson
Independent Director
Ms. Kathy Weiler
Independent Director
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Mr. Alan M. Levine
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Erick Wayne Devinney
Chief Innovation Officer
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Lindsey Hartley
Chief Financial Officer
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
Mr. John H. Johnson
Independent Director
ROBO Global Healthcare Technology & Innovation ETF
SPDR S&P Health Care Equipment ETF
iShares Neuroscience and Healthcare ETF
Fidelity Digital Health ETF
Invesco NASDAQ Future Gen 200 ETF
AAM Sawgrass US Small Cap Quality Growth ETF
Fidelity Enhanced Small Cap ETF
Vanguard US Momentum Factor ETF
Franklin US Small Cap Multifactor Index ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
ROBO Global Healthcare Technology & Innovation ETF
āļŠāļąāļāļŠāđāļ§āļ1.87%
SPDR S&P Health Care Equipment ETF
āļŠāļąāļāļŠāđāļ§āļ1.2%
iShares Neuroscience and Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ1.14%
Fidelity Digital Health ETF
āļŠāļąāļāļŠāđāļ§āļ0.89%
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļāļŠāđāļ§āļ0.45%
AAM Sawgrass US Small Cap Quality Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.44%
Fidelity Enhanced Small Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.13%
Vanguard US Momentum Factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.11%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.11%
Franklin US Small Cap Multifactor Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.07%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ